Greenbrook TMS Inc. is a leading provider of Transcranial Magnetic Stimulation (TMS) therapy and Spravato® (esketamine nasal spray), FDA-cleared and non-invasive therapies for the treatment of Major Depressive Disorder (MDD) and other mental health disorders in the United States. The company operates through 130 Company-operated treatment centers and has provided more than 1.3 million treatments to over 40,000 patients struggling with depression.